Direct interaction of the Golgi membrane with the endoplasmic reticulum membrane caused by nordihydroguaiaretic acid.
Nordihydroguaiaretic acid (NDGA), an inhibitor of lipoxygenase, blocks protein transport from the endoplasmic reticulum (ER) to the Golgi complex and induces the redistribution of Golgi proteins into the ER. We investigated characteristics of NDGA-induced retrograde movement of the Golgi proteins to the ER. At an early stage of incubation of cells with NDGA, the Golgi complex formed convoluted membrane aggregates. Electron microscopy revealed that these aggregates directly interact en bloc with the ER membrane. The direct interaction and subsequent incorporation of the Golgi proteins into the ER were found to be temperature-dependent. The protein of ER-Golgi intermediate compartment (ERGIC), ERGIC53, was rapidly accumulated in the Golgi upon treatment with NDGA. This accumulation was significantly inhibited by low temperature at 15 degrees C. Under the condition, the redistribution of the Golgi proteins into the ER as well as the direct interaction between the ER and the Golgi by NDGA were also inhibited, suggesting an important role of the ERGIC in the retrograde movement. In contrast, the low temperature did not inhibit formation of the Golgi aggregates by NDGA. Taken together, these results suggest that NDGA causes the redistribution of the Golgi proteins into the ER through the direct connections between the Golgi, the ERGIC, and the ER.
Fujiwara
Toshiyuki
T
Department of Cell Biology, Fukuoka University School of Medicine, Nanakuma, Jonan-ku, 814-0180, Fukuoka, Japan.
Misumi
Yoshio
Y
Ikehara
Yukio
Y
D002460:Cell Line; D003080:Cold Temperature; D004721:Endoplasmic Reticulum / Q000187:drug effects*; D006056:Golgi Apparatus / Q000187:drug effects*; D006801:Humans; D007425:Intracellular Membranes / Q000187:drug effects; D016859:Lipoxygenase Inhibitors / Q000494:pharmacology; D009637:Masoprocol / Q000494:pharmacology*; D008854:Microscopy, Electron; D021381:Protein Transport / Q000187:drug effects
D016859:Lipoxygenase Inhibitors; D009637:Masoprocol